Search
Not a candidate for surgery or radioactive iodine therapy
go.drugbank.com/conditions/DBCOND0122488Drugs: MethimazoleSynonyms: Not a candidate for surgery or radioactive iodine therapyCancer Patients Eligible for a Treatment With Curative Intent
go.drugbank.com/conditions/DBCOND0063540Drugs: AzacitidineSynonyms: Cancer Patients Eligible for a Treatment With Curative IntentIfosfamide
go.drugbank.com/drugs/DB01181ApprovedInvestigationalIfosfamide is a chemotherapeutic agent chemically related to the nitrogen mustards and a synthetic analog of cyclophosphamide. It is active as an alkylating agent and an immunosuppressive agent.
Categories: Cytochrome P-450 CYP2A6 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic IndexSynonyms: 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxideHeparin
go.drugbank.com/drugs/DB01109ApprovedInvestigationalIt is a naturally occurring anticoagulant released from mast cells. … partial prothrombin time (aPTT) monitoring is required when using UH; and UH has a higher risk of bleeding and higher risk of osteoporosis in long term use.
Mixtures: Heparin Sodium & Dextrose 5% In Viaflex Liq, Heparin Sodium 20000units In 5% Dextrose InjProducts: HEPARIN AL GEL 30000, HEPARIN AL GEL 50000Double-refractory to a proteasome inhibitor and an immunomodulatory agent
go.drugbank.com/conditions/DBCOND0024034Synonyms: Double-refractory to a proteasome inhibitor and an immunomodulatory agentEphedra sinica root
go.drugbank.com/drugs/DB01363ApprovedNutraceuticalThe sale of ephedra-containing supplements intended to increase muscle weight or promote weight loss was banned in the United States in 2004 due to the risk for adverse effects and a lack of evidence for … Ephedra is an alkaloid chemical compound traditionally obtained from the plant _Ephedra sinica_.
Mixtures: Miller's Formula No. 1Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates, Adrenergic alpha-2 Receptor AgonistsDexamethasone
go.drugbank.com/drugs/DB01234ApprovedInvestigationalVet approved[L10695] In a press release for the Randomized Evaluation of COVID-19 Therapy (RECOVERY) trial on 16 June 2020, dexamethasone was recommended for use in COVID-19 patients with severe respiratory symptoms … Dexamethasone, or MK-125, is a corticosteroid fluorinated at position 9 used to treat endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic
Synonyms: 16α-Methyl-9α-fluoro-1-dehydrocortisol, 1-Dehydro-16α-methyl-9α-fluorohydrocortisoneInternational brands: Dexa-sineCarboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1
go.drugbank.com/bio_entities/BE0004551TargetHumansPreferentially catalyzes the dephosphorylation of 'Ser-5' within the tandem 7 residue repeats in the C-terminal domain (CTD) of the largest RNA polymerase II subunit POLR2A. Negatively regulates RNA polymerase II transcription, possibly ...
Polypeptides: Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1Fish oil
go.drugbank.com/drugs/DB13961ApprovedInvestigationalNutraceuticalFish oil is a component of SMOFLIPID, which was FDA approved in July 2016. … demonstrated abilities in minimizing or preventing hypertriglyceridemia when taken as an adjunct to a healthy diet [FDA Label].
Mixtures: Protect Cardio AF, Hovid Omega-3 + 6Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A SubstratesSI-109
go.drugbank.com/drugs/DB32603ExperimentalSI-109 is a potent, small-molecule inhibitor of the STAT3 SH2 domain.[A275443]